University Hospitals Center Focusing on All Things Diabetes

Share
Facebook
Twitter
Pinterest
LinkedIn
Email
Print

Improving physician recommendations and offering continuous glucose monitoring in patients are the goals of the UH Diabetes and Obesity Center

UHCMC Update | May 2021

Diabetes continues to be a significant source of serious illness and shortened lifespan in the U.S., affecting 10% of the population (American Diabetes Association data, 2018). And of those with diabetes, around 20% were not diagnosed with diabetes until presenting with a health concern.

Diabetes continues to be a significant source of serious illness and shortened lifespan in the U.S., affecting 10% of the population (American Diabetes Association data, 2018). And of those with diabetes, around 20% were not diagnosed with diabetes until presenting with a health concern.

As the rates of diabetes and obesity continue to rise, a dedicated team of physicians at UH Cleveland Medical Center is making sure that clinical monitoring and knowledge about diabetes is on the minds of UH physicians and patients.

Betul Hatipoglu, MD, Vice Chair, UH System Clinical Affairs, Department of Medicine, and Medical Director, Diabetes & Obesity Center, at UH Cleveland Medical Center, said she has many exciting plans in the works regarding “all things diabetes.” Dr. Hatipoglu, Jillian Fetzner, MSN, APRN-CNP, and Nick Galloway, BSN, RN, CDCES, are expanding their team while building the UH Diabetes and Obesity Center.  “Together, one of our first initiatives is to meet with primary care offices to make them aware of available diabetes resources,” said Dr. Hatipoglu. “We are most excited to offer to meet with primary care offices to review complex diabetes cases and provide recommendations to the primary care team.”

The UH Diabetes and Obesity Center is also developing a real-time continuous glucose monitoring clinic that has been shown to be beneficial in both Type 1 and Type 2 patients with diabetes to evaluate pattern management.  “All providers are welcome to place an order and your patients will be scheduled for two visits.  One, to place a professional continuous monitor and two weeks later, to remove the device,” said Dr. Hatipoglu. “We will provide education to the patient on wearing a continuous glucose monitor as well as recommendations for medication changes or lifestyle changes after downloading the device and doing an analysis of the data.”

The clinic will begin placing Eversense implantable continuous glucose monitors for use in patients up to 90 days. Please contact us at DiabetesHelpline@UHhospitals.org or ask the Diabetes Help Line for more information. 

Share
Facebook
Twitter
Pinterest
LinkedIn
Email
Print